Skip to main content

Pharmaceuticals

Pharma Bad Boy Martin Shkreli Kicked Off Twitter for Harassment
INVESTING
TSLATWTR

Martin Shkreli Is Excited To Rejoin Elon Musk's Twitter

By Michael Tedder
Biohaven Pharmaceutical Company
MARKETS
PFEBHVN

Khloé Kardashian-Endorsed Migraine Drugmaker Biohaven Sold To Pfizer For $11.6 Billion

By Martin Baccardax
PharmaCyte Biotech Lead
INVESTING
XBI

Biotechs Weakened by The Stock Market Rout

By Ellen Chang
Moderna Lead
MARKETS
MRNAPFE

Moderna Stock Active After Smashing Q1 Earnings Forecast, Affirming Vaccine Sales Forecast

By Martin Baccardax
NYSE Trader Lead
MARKETS
TWTRTSLABIIB

Stock Market Today - 5/3: Stocks End Higher Amid Fed Rate Hike Bets; Treasury Yields Ease

By Martin Baccardax and Rob Lenihan
Biogen Lead
MARKETS
BIIB

Biogen Stock Gains After Q1 Earnings Miss; CEO Michel Vounatsos Exits

By Martin Baccardax
Pfizer Lead
MARKETS
PFE

Pfizer Tops Q1 Earnings Forecast on Covid Vaccine Sales, Cuts 2022 Profit Outlook

By Martin Baccardax
Pfizer Pill Lead
MARKETS
PFE

Pfizer Stock Slides As Data From Covid Antiviral Trial Disappoints Ahead Of Q1 Earnings

By Martin Baccardax
NYSE Trader Lead
MARKETS
FBAAPLF

Stock Market Today - 4/28: Stocks Bounce Back, Tech Boost; GDP Disappoints, Apple In Focus

By Martin Baccardax
Merck Is Dangerously Close to a Breakdown
MARKETS
MRK

Merck Stock Gains As Covid, Keytruda Sales Help Q1 Earnings Beat, Profit Forecast Boost

By Martin Baccardax
Eli Lilly Lead
MARKETS
LLY

Eli Lilly Stock Leaps As Trulicity Sales Drive Q1 Earnings Beat, Obesity Drug Trial Data

By Martin Baccardax
Johnson & Johnson Lead
INVESTING
JNJ

JNJ Stock Alert: Buy Johnson & Johnson on Push to All-Time Highs?

By Bret Kenwell
NYSE Stock Market Trader Lead
MARKETS
JNJHASTWTR

Stock Market Today - 4/19: Dow Ends Up Nearly 500 Points Amid Hawkish Fed Risks, Mixed Earnings Reports

By Martin Baccardax and Rob Lenihan
Johnson & Johnson's vaccine Lead
MARKETS
JNJ

Johnson & Johnson Suspends Vaccine Sales Guidance, Boosts Dividend; Stock Hits Record High

By Martin Baccardax
NYSE Trader Lead
INVESTING
KMXVERUCSCO

Stock Market Today - 4/12: Stocks End Down as Inflation Hits Highest Level Since 1981

By Martin Baccardax and Rob Lenihan
BioCryst Pill Prevents Swelling Attacks but Shares Fall on Competitive Concerns
MARKETS
VERUPFEMRK

Veru Stock Soars, Retreats After Impressive Data From Covid Treatment Trial

By Martin Baccardax
AbbVie Q3 Revenue Misses, Shares Decline
INVESTING
ABBV

Sometimes You Have to Sell a Stock You Love

By Ellen Chang
Vertex Pharmaceuticals Lead
TECHNOLOGY
VRTXAMGNABBV

Vertex Has a Pain Pill That May Replace Opioids

By Ellen Chang
SciClone And Joinn Laboratories Set To Joining Frenzy For Biotech IPOs In Hong Kong As Fundraising Jumps To Highest In Two Years
TECHNOLOGY
XBIMRNAOCGN

Biotech Stocks Are Cheap. Is It Time for Blockbuster M&A?

By Ellen Chang
Walgreens Lead
MARKETS
WBA

Walgreens Stock Slumps After Q2 Earnings Beat, 2022 Guidance Hold

By Martin Baccardax
Pfizer BioNTech Moderna Lead
MARKETS
PFEMRNA

Pfizer, Moderna Win FDA Approval of Fourth Covid Shot

By Martin Baccardax
Biogen ALS Lead JS
TECHNOLOGY
BIIBIONS

Biogen's ALS Drug Won't Move Forward After Trial Failures

By Vidhi Choudhary
Taiwan has signed a deal to buy a total of 20 million doses, including from Britain's AstraZeneca and Moderna in the US. Photo: Reuters
INVESTING
FDXMRNAAPA

Stocks of the Week: FedEx, Moderna, APA

By Brian O'Connell
Jim Cramer: Walgreens is a buy After the Stock Settles Down
INVESTING
WBA

New Walgreens Doors Are Also Watching You

By Riley Gutiérrez McDermid